IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

RIBERO, MARIALISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.926
NA - Nord America 4.797
AS - Asia 4.289
SA - Sud America 395
AF - Africa 82
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 1
Totale 15.499
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.636
GB - Regno Unito 2.726
SG - Singapore 1.348
CN - Cina 1.227
IT - Italia 788
RU - Federazione Russa 579
SE - Svezia 370
TR - Turchia 343
HK - Hong Kong 328
UA - Ucraina 321
DE - Germania 309
VN - Vietnam 309
BR - Brasile 265
FR - Francia 241
KR - Corea 236
IN - India 198
IE - Irlanda 188
NL - Olanda 151
BD - Bangladesh 135
FI - Finlandia 135
EU - Europa 125
CA - Canada 110
CO - Colombia 58
AR - Argentina 33
ID - Indonesia 24
GR - Grecia 21
CI - Costa d'Avorio 20
JP - Giappone 20
IQ - Iraq 19
MX - Messico 19
PL - Polonia 19
UZ - Uzbekistan 17
ZA - Sudafrica 16
SA - Arabia Saudita 15
BE - Belgio 11
EC - Ecuador 11
ES - Italia 11
PK - Pakistan 10
PY - Paraguay 8
VE - Venezuela 8
AT - Austria 7
AU - Australia 7
DK - Danimarca 7
MA - Marocco 7
MY - Malesia 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
EG - Egitto 6
PH - Filippine 6
DO - Repubblica Dominicana 5
KE - Kenya 5
LT - Lituania 5
UY - Uruguay 5
BY - Bielorussia 4
CH - Svizzera 4
CL - Cile 4
CR - Costa Rica 4
IL - Israele 4
LU - Lussemburgo 4
TN - Tunisia 4
AO - Angola 3
AZ - Azerbaigian 3
DZ - Algeria 3
ET - Etiopia 3
GT - Guatemala 3
IR - Iran 3
JM - Giamaica 3
JO - Giordania 3
KG - Kirghizistan 3
KZ - Kazakistan 3
NI - Nicaragua 3
PT - Portogallo 3
RO - Romania 3
SO - Somalia 3
AM - Armenia 2
BB - Barbados 2
CD - Congo 2
CZ - Repubblica Ceca 2
DM - Dominica 2
EE - Estonia 2
GA - Gabon 2
KH - Cambogia 2
LB - Libano 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
PS - Palestinian Territory 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
BZ - Belize 1
CM - Camerun 1
Totale 15.602
Salva come PNG Salva come JPEG
Città #
Southend 2.651
Singapore 719
Ashburn 465
Beijing 362
Chandler 350
Seattle 341
San Jose 335
Hong Kong 318
Santa Clara 264
Jacksonville 236
Princeton 236
Dublin 186
Wilmington 171
Redmond 165
Milan 155
Kent 138
Council Bluffs 129
Bengaluru 114
Mountain View 113
Sakarya 111
Los Angeles 107
Lauterbourg 105
Dallas 101
Nanjing 101
Boardman 89
Des Moines 87
Ho Chi Minh City 80
Moscow 68
Hanoi 66
Serra 66
Buffalo 65
Ann Arbor 64
Andover 57
Toronto 55
Bogotá 54
Shanghai 51
Dearborn 50
Saint Petersburg 47
Hefei 44
New York 42
Rome 39
Shenyang 34
Nanchang 33
Guangzhou 32
Tianjin 32
The Dalles 30
Columbus 28
Dong Ket 28
Hanover 28
Jinan 28
Ottawa 28
Woodbridge 28
Cangzhou 22
Berlin 21
Frankfurt am Main 21
Abidjan 20
Munich 20
São Paulo 20
Fairfield 19
Chicago 18
Fuzhou 18
Medford 18
Tokyo 18
Houston 17
San Diego 16
Shenzhen 16
Warsaw 16
Bitonto 15
Changsha 15
Da Nang 15
Seoul 15
Athens 14
Hebei 13
Jiaxing 13
Mumbai 13
Helsinki 12
Palermo 12
Somerville 12
Baghdad 11
Belo Horizonte 11
Brussels 11
Turin 11
Turku 11
Verona 11
Haiphong 10
Johannesburg 10
Pune 10
Redwood City 10
Fremont 9
Ningbo 9
Eitensheim 8
London 8
Naples 8
Orem 8
Washington 8
Bologna 7
Brooklyn 7
Chennai 7
Dhaka 7
Florence 7
Totale 9.954
Salva come PNG Salva come JPEG
Nome #
Hepatitis B virus infection in dentists and dental students 371
Prevalence of naturally occurring S-gene mutants of hepatitis B virus in HBsAg negative patients with hepatocellular carcinoma and controls 368
The ability of Procleix Ultrio assay to detect HBV DNA in HBsAg positive blood donors 236
Trasmissione verticale dell’infezione da HBV in bambini sottoposti a immunoprofilassi anti-epatite B 234
Mother-infant transmission of hepatitis B virus (HBV) infection in children receiving full passive and active immunoprophylaxis 233
Occult hepatitis B virus and hepatocellular carcinoma : a case-control study 230
Alcohol dehydrogenase 3, glutathione S-transferase M1 and T1 polymorphisms, alcohol consumption and hepatocellular carcinoma (Italy) 211
Reinfection of liver graft by hepatitis B virus in transplant recipients with occult hepatitis B 209
Mutations within the CD81-binding sites and hypervariable region 2 of the envelope 2 protein and hepatitis C recurrence after liver transplantation 208
Antibodies to hepatitis C virus in blood donors 206
A randomized trial of prolonged high dose of interferon plus ribavirin for hepatitis C patients nonresponders to interferon alone 203
Prevalenza dell'infezione occulta da HBV in donatori di sangue con anti-HBc-Ag isolato vaccinati contro l'epatite B 199
GENOTIPI DELL'HCV IN PAZIENTI SOTTOPOSTI A TRAPIANTO DI FEGATO PER EPATOCARCINOMA SU CIRROSI 197
Clinical significance of hepatic HCV RNA in patients with chronic hepatitis C demonstrating long-term sustained response to interferon-alpha therapy 190
N-Acetyltransferase-2, glutathione S-transferase M1 and T1 genetic polymorphisms, cigarette smoking and hepatocellular carcinoma: A case-control study 186
Polimorfismi genetici degli enzimi N-acetiltransferasi 2 e glutatione-s-transferasi, fumo di tabacco e rischio di epatocarcinoma 185
Occult hepatitis B in patients with hepatocellular carcinoma and controls with and without hepatitis C infection 185
Maternal-infant transmission of HCV infection 183
Maternal-infant transmission of hepatitis C virus and HIV infections: a possible interaction 183
Analisi dei donatori di sangue RIBA HCV indeterminati con l'uso di peptidi sintetici 182
Hepatitis G and C virus coinfection in children 176
Coffee consumption reduces the risk of hepatocellular carcinoma independently of its aetiology : a case-control study 173
Prevalence of S-gene mutants of hepatitis B virus in Italian blood donors and patients with chronic HBV infection 173
Hepatitis B virus S-gene mutants in HBsAg positive blood donors and in patients with hepatocellular carcinoma and controls with overt or occult HBV infection 172
Association between HLA DQB1*03 and HBV-related hepatocellular carcinoma 171
Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma : the role of HCV genotypes and the synergism with hepatitis B virus and alcohol 169
Infezione occulta da virus dell'epatite B in donatore di cellule staminali emopoietiche e ricevente con mieloma multiplo 168
Il ruolo della vaccinazione nella prevenzione dell'epatite virale di tipo B: Aspetti storici ed attualita 168
Antibodies to hepatitis C virus in community-acquired acute non-A, non-B hepatitis 166
Acute non-A, non-B hepatitis in Italy: a 16-year prospective epidemiological study. The possible role of hepatitis C virus 163
Hepatitis C virus genotype in anti-HCV-positive hemodialysed patients 161
Vertical transmission of hepatitis C virus in infants born to HCV and HIV seropositive mothers 161
Outcome of an outbreak of acute hepatitis C among healthy volunteers participating in pharmacokinetics studies 157
Long-Term Surveillance of Allogeneic and Autologous Hemopoietic Stem Cell Transplant Recipients Affected by Primary Occult Hepatitis B Virus Infection 157
Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake and hepatolithiasis : a case-control study in Italy 155
Prevalence of GB virus-C/hepatitis G virus infection in patients with cryptogenic chronic liver disease and in patients with primary biliary cirrhosis or Wilson's disease 153
A case-control study on GB virus C/hepatitis G virus infection and hepatocellular carcinoma 152
Alpha-Interferon therapy in patients with HCV and HGV coinfection : changes in quantitative HCV and HGV RNA levels 151
Prophylaxis against HCV recurrence after liver transplantation : effect of interferon and ribavirin combination 150
Hepatitis C virus (HCV) in lymphocyte subsets and in B lymphocytes expressing rheumatoid factor cross-reacting idiotype in type II mixed cryoglobulinemia 148
A hepatitis B vaccination programme in a group of dental practitioners 148
Profilo sierologico dell'epatite C acuta e cronica post-trasfusionale 147
Prevalence of 1762T 1764A mutations in the basic core promoter of HBV isolated from patients with hepatocellular carcinoma and controls 146
L'infezone da virus dell’epatite B nel personale di odontoiatria 146
Reattività anticorpali anti-HBcAg discordanti tra metodiche sono predittive per la presenza di infezioni occulte da HBV? 145
A long term study of hepatitis G virus coinfection in chronic hepatitis B 145
The prevalence of HCV infection in a cohort of pregnant women, the related risk factors and the possibility of vertical trasmission 144
Natural history of chronic hepatitis C in children 144
A case-control study on a novel DNA virus (TT virus) infection and hepatocellular carcinoma 143
Hepatitis C outbreak in health-care workers partecipating in pharmacokinetic studies: biochemical, virological and histological outcome 143
Prevalence of markers to hepatitis B virus in dentists in eastern Lombardy 143
Antibody to hepatitis C virus in cryptogenic chronic liver disease 142
Alcohol and hepatocellular carcinoma : the effect of lifetime intake and hepatitis virus infections in men and women 142
Antibodies to hepatitis C virus in children with acute or chronic viral hepatitis 141
Primary liver cancer and occupation in men : a case-control study in a high-incidence area in Northern Italy 140
Hepatitis C virus genotypes : distribution and clinical significance in patients with cirrhosis type C seen at tertiary referral centres in Europe 140
Consensus interferon (CIFN) in combination with ribavirin (RBV) for naive patients with chronic hepatitis C : a multicenter study 139
Occult Hepatitis B in patients with hepatocellular carcinoma and controls with and without hepatitis C virus infection 139
Antibody to hepatitis C virus in post-transfusion hepatitis 139
Hepatitis B and C virus infection, alcohol drinking and hepatocellular carcinoma : a case-control study in Italy 138
Response to interferon treatment in patients with chronic hepatitis and HCV/HGV coinfection 138
Hepatitis C virus genotypes in patients with essential mixed cryoglobulinemia 137
Detection of antibody to HIV env glycoprotein in blood donors with indeterminate results on Western blotting 135
Infezione occulta da virus dell’epatite B in pazienti con epatocarcinoma e controlli con o senza infezione da HCV 134
Changes of antibody titer to hepatitis C virus during Interferon therapy of cryptogenic chronic active liver disease 133
Influence of GB virus-C/hepatitis G virus infection on the long term course of chronic hepatitis B 131
Anti-HCV response in post-transfusion hepatitis (PTH). 130
Prevention of recurrent hepatitis C after liver transplantation with early interferon and ribavirin treatment 127
Quantitation and typing of hepatitis C Virus RNA in patients on interferon and ribavirin prophylaxis after liver transplantation 127
Effect of hepatitis C genotype on mother-to-infant transmission of virus 127
Evolutionary and molecular aspects of surface antigen (HBsAg) gene mutants in blood donors with occult Hepatitis B virus infection 126
A case-control study on family history of liver cancer as a risk factor for hepatocellular carcinoma in North Italy : Brescia HCC Study 125
Significance of hepatitis C virus genotypes and viral load in patients with "essential" mixed cryoglobulinemia 124
Hepatitis C virus infection and chronic liver disease in children with leukemia in long-term remission 124
A randomized trial of consensus interferon in combination with ribavirin as initial treatment for chronic hepatitis C 123
Etiology of hepatocellular carcinoma in Italian patients with and without cirrhosis 123
Effetto della terapia antiretrovirale sulla viremia da HCV e sull'epatite C in una coorte di pazienti HIV positivi 123
Hepatitis C virus infection in patients with hematological malignancies treated with chemotherapy or bone marrow transplantation (BMT). 123
A case-control study on hepatitis G virus and hepatocellular carcinoma in Italy 123
Transient loss of HGV induced by interferon treatment does not modify the response of HCV in chronic hepatitis 122
Changes of anti-HCV antibodies in chronic hepatitis C during interferon therapy 122
Profilassi con Interferone e ribavirina in pazienti HCV-RNA postivi sottoposti a trapianto di fegato: una nuova strategia contro la recidiva di epatite C 122
IFN alpha 2B and ribavirin in naive patients with HCV type 1 chronic hepatitis : results after 6 months of therapy 121
HCV genotype and response to interferon therapy in chronic hepatitis 120
Influence of GB virus-C/hepatitis G virus infection on the long term course of chronic hepatitis B 118
Etiology of hepatocellular carcinoma influences clinical and pathologic features but not patient survival 116
Epidemiology of tetanus 116
A case-control study on the role of hepatitis C virus genotypes in hepatocellular carcinoma in North Italy 116
Amount and duration of alcohol intake in development of hepatocellular carcinoma : a case-control study in Italy 116
Relationship between serum HCV markers and response to interferon therapy in chronic hepatitis C. Evaluation of HCV genotypes during and after long-term follow-up 115
Persistence of immunity following hepatitis B vaccination in dental practitioners 111
High circulation of hepatitis C virus in drug abusers with acute viral hepatitis :epidemiological and clinical implications 111
Experience with interferon-alpha 2B and ribavirin prophylaxis after liver transplantation in HCV RNA positive recipients 107
Structural and non-structural HCV antibody seroconversion in NANB post-transfusion hepatitis (PTH) 106
HCV genotyping may be useful to determine the real diffusion of HCV from HCV chronic patients to their household relatives 102
Hepatitis G virus infection in cryptogenic chronic liver disease : is there a role ? 101
Hepatitis C genotype and clinical outcome of compensated cirrhosis type C 101
Hepatitis C viremia in a cohort of blood donors with different RIBA 3.0 results 100
HGV infection in patients affected with HCV chronic liver disease: prevalence and eligibility to the interferon treatment 99
Ribavirin plus alfa interferon in the treatment of chronic hepatitis C unresponsive to alfa interferon 96
Totale 15.268
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.825
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.825
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022844 40 15 12 95 39 45 62 37 71 122 98 208
2022/20231.220 176 102 74 194 160 292 17 49 102 15 31 8
2023/2024799 14 62 21 11 112 16 15 250 11 117 92 78
2024/20251.910 68 289 19 263 225 17 30 216 94 94 177 418
2025/20263.913 470 186 460 284 318 276 372 248 486 363 191 259
2026/2027118 118 0 0 0 0 0 0 0 0 0 0 0
Totale 16.356